Zara Hakima YAHI. PhD.,MBA

CNU Maître de conférence Universitaire https://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000017572891

STEM WOMEN CONGRESS (SWC) is an global initiative aiming to reduce gender inequality in the STEM sectors. Our platform aims to quantify the magnitude and the impact that STEM initiatives have on reducing this inequality.

Leading & coaching 11 MSLs and senior MSLs direct reports across Canada Medical science team leadership and management, including recruitment, onboarding, coaching and development of medical science liaisons, performance evaluation and brand prioritization. • Represent field medical affairs in Canadian Medical Affairs Leadership Team and Canada in Global Field Medical Excellence teams. • Manage resources, including budget, to address field medical business needs and ensure adherence to financial targets. • Review and approve business objectives, track performance and quality metrics, and conduct performance appraisals of medical science liaisons.

Responsible for Oncology medical affairs with 8 direct reports. Recruited and reorganized a territory of senior Medical science liaisons and MSL. Overseen performance and development. Leading actionable insights initiatives Managing cross-functional collaboration and fostering cross-functional teamwork within three different franchises. Active working member of AZ Global MSL excellence group An active member of FMT, Field medical team group

https://pharmabio.qc.ca/regard/octobre-2016/mission-accomplie-ssp-2/

Product portfolio is centred in three therapeutic areas: Hematology coagulation factors to treat bleeding disorders. Critical Care Plasma proteins used to stabilize blood circulation and restore coagulation function. Immunotherapy Immunoglobulins to treat a variety of immunity related disorders.

https://www.youtube.com/watch?v=xLf1Qir3Ess&feature=share http://argent.canoe.ca/videos/video-dre-hakima-yahi

Most important, 1- Yahi H.et al.Direct interaction between P-gp and HERG in Human Heart (Submitted article) 2- M. Zakrzewski-Jakubiak, R. Hreiche, H. Yahi-Kerbane and J. Turgeon. The multidrug resistance protein 7. Clinical Pharmacology and Therapeutics, 2008 3- Yahi H. et al. Differential Cooperation ... The Journal of biological chemistry 2008 3- Yahi H. et al. Chromatin modification and muscle differentiation, Review, Expert Opinion on therapeutic targets 2006 Dec 4- Yahi H. et al. La 48 ième réunion annuelle du CRCQ, club recherche clinique du Québec, 21-23 Septembre 2006 QUEBEC, CANADA. Médecine science Volume 22, Supplément N°2, 2006 5- R. Hreiche, F. Briec, A., H. Yahi, and J. Turgeon, Gender Differencies in the Electrophisiological effects , ASCPT, Technical Innovation in Clinical Pharmacoclogy. Mars 21-24 Anaheim, Ca. USA 6- H. Yahi, and al. A Suv39h dependent mechanism for silencing S-phase genes is used in differentiating cells but not in cycling cells. EMBO J 2004

Most important, 1- Yahi H.et al.Direct interaction between P-gp and HERG in Human Heart (Submitted article) 2- M. Zakrzewski-Jakubiak, R. Hreiche, H. Yahi-Kerbane and J. Turgeon. The multidrug resistance protein 7. Clinical Pharmacology and Therapeutics, 2008

1- Viens, A, Yahi H, et al. Dynamique chromatinienne. Ouvrage: Cancérologie Fondamentale, Édité par : C. Larsen, R. Lacave, et J. Robert, John Libbey Editions, 2005 2- Guasconi V., Yahi H et al. Transcription factors. Atlas Genet Cytogenet Oncol Haematology: www.infobiogen.fr/services/chromcancer/GeneticEng . 2003. 3- Harel-bellan A., Yahi H, et al.. Gene Silencing through RNAi. Biotech Médecine N°27, 2003. 4. Yahi, H and Thomas,S.R. Anaerobic glycolytic Lactate production in the Urine Concentrating Mechanism: Exploration in 2D (Flat) and 3D Mathematical Models. Journal of the American Society of Nephrology, November 2002.